Eli Lilly agrees to acquire Ajax for up to $2.3B cash, gaining experimental blood cancer treatments.
Eli Lilly agreed to buy closely held Ajax for as much as $2.3 billion in cash to gain promising experimental medicines for blood cancers
What happened
Eli Lilly agreed to buy closely held Ajax for as much as $2.3 billion in cash to gain promising experimental medicines for blood cancers
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
See this on the live map
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
More story pages
Canadian Prime Minister Mark Carney announces creation of a sovereign wealth fund.
Canadian Prime Minister Mark Carney announced the creation of a sovereign wealth fund.
ECB staff say US bank capital rules tougher than EU, rebutting industry calls for lighter regulation
ECB staff said the United States imposes tougher capital requirements on large banks than the European Union, pushing back against arguments from the banking industry for weaker regulations in the region.
Iran's President orders the elimination of human resources contracting companies, according to the Head of the Supreme Council of Islamic Labor Councils.
The President of Iran has issued a directive to eliminate contracting companies that provide human resources, according to the Head of the Supreme Council of Islamic Labor Councils.
SpaceX aims for record $1.75 trillion IPO, but valuation hinges on unproven tech, Reuters finds
SpaceX is preparing for what could be the largest IPO in history, valuing the company at $1.75 trillion, but Reuters reports that the valuation depends on unproven technology.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.